Clinical validation of an RSV neutralization assay and analysis of cross-sectional sera associated with 2021–2023 RSV outbreaks to investigate the immunity debt hypothesis
ABSTRACT Respiratory syncytial virus (RSV) is a leading cause of acute respiratory infections and hospitalization in infants and the elderly. Newly approved vaccines and the prophylactic antibody nirsevimab have heightened interest in RSV immunologic surveillance, necessitating the development of hi...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology
2024-12-01
|
| סדרה: | Microbiology Spectrum |
| נושאים: | |
| גישה מקוונת: | https://journals.asm.org/doi/10.1128/spectrum.02115-24 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|